DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 6Dr. Reddy's Laboratories
02 3Lee Fine Chem
03 1Olpha
04 3NanoAlvand
05 2Aizant Drug Research Solutions Pvt. Ltd.
06 2Aurobindo Pharma Limited
07 3Bluepharma
08 3Cipla Medpro South Africa
09 3MSN Laboratories
10 1NANO DARU
11 3Pfizer Consumer Healthcare
12 21Pfizer Inc
13 3Pharmascience Inc.
14 6Pinnacle Life Science
15 3Pluviaendo
16 3Sun Pharmaceutical Industries Limited
17 3Taro Pharmaceutical Industries
18 3Tecnimede
19 1TherDose Pharma
20 3XYZ Pharma
21 3Zydus Lifesciences
01 6CAP
02 3CAPSULE; ORAL
03 13CAPSULE;ORAL
04 3Caps
05 10Capsule
06 3Capsule, hard
07 3Capsules
08 3Filmtabl
09 3Hard Capsules
10 3Hard Gelatin Capsule
11 3Oral Solid Dosage Form
12 9TABLET
13 6TABLET;ORAL
14 7Tablet
15 1Tablets
16 3Blank
01 3DISCN
02 1Dossier Readiness: Q3 2025
03 3Generic
04 3Lead Market Dossiers- Filed
05 3Lead Market Dossiers- Tentative\nApproved in US
06 3Originator
07 6RX
08 57Blank
01 3Cybrin
02 9IBRANCE
03 12Ibrance
04 16PALBOCICLIB
05 3PMS-PALBOCICLIB
06 6Palbociclib
07 1Palbociclib 100 mg Cipla
08 1Palbociclib 125 mg Cipla
09 1Palbociclib 75 mg Cipla
10 1Palbociclib Pfizer 100 mg
11 1Palbociclib Pfizer 125 mg
12 1Palbociclib Pfizer 75 mg
13 3TARO-PALBOCICLIB
14 21Blank
01 3Australia
02 9Canada
03 16India
04 4Iran
05 1Latvia
06 3Norway
07 6Portugal
08 6South Africa
09 6Switzerland
10 3Turkey
11 22USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
Brand Name :
Dosage Form : Oral Solid Dosage Form
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Filed
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Lead Market Dossiers- Tentative\\nApproved in US
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
